Atrial fibrillation is detected primarily through an electrocardiogram (ECG), which records your heart’s electrical activity and reveals the characteristic irregular rhythm pattern. But because afib can come and go unpredictably, catching it often requires monitoring that extends well beyond a single office visit. Detection methods range from a doctor checking your pulse to smartwatches that alert you to irregular rhythms, and the right approach depends on whether symptoms are constant, intermittent, or completely absent.
What a Doctor Checks First
The simplest screening tool is one you can try yourself: feeling your pulse. A normal heart produces a steady, rhythmic beat, while afib creates a pattern often described as “irregularly irregular,” meaning there’s no predictable spacing between beats. In primary care settings, manual pulse palpation picks up afib with about 63% sensitivity and 92% specificity. That means it catches roughly two-thirds of actual afib cases but rarely flags a normal rhythm as abnormal. It’s a useful first step, but not reliable enough on its own to confirm or rule out the condition.
If your pulse feels irregular, or if you’re experiencing symptoms like palpitations, shortness of breath, or unexplained fatigue, the next step is a standard 12-lead ECG. This takes about 10 seconds of recording and provides the definitive snapshot doctors use to diagnose afib.
What an ECG Reveals
On a normal ECG tracing, each heartbeat produces a distinct set of waves. The P wave represents the electrical signal that fires in the upper chambers (atria) before each beat. In afib, P waves disappear entirely. Instead, the atria fire chaotically, sometimes producing small, rapid “fibrillatory waves” on the tracing. The baseline of the recording, which is normally flat between beats, becomes wavy and uneven.
The other hallmark is the spacing between heartbeats. In a normal rhythm, the intervals are evenly spaced. In afib, they vary randomly. A doctor or technician can spot this irregularity within seconds of looking at the tracing. The heart rate itself also fluctuates, often running faster than normal, though it can be slow or near-normal depending on the individual. The electrical signal through the lower chambers (ventricles) usually looks normal, which helps distinguish afib from other rhythm problems.
Catching Afib That Comes and Goes
A standard ECG only captures a few seconds of heart activity. If your afib is intermittent, also called paroxysmal, there’s a good chance your heart will be in a normal rhythm during that brief recording. This is where extended monitoring becomes essential.
A Holter monitor is a portable device you wear continuously for 24 to 48 hours. It records every heartbeat during that window, and the data is later analyzed for any irregular episodes. Holter monitors work well when symptoms happen at least daily, but their short recording window misses a lot. Studies comparing detection methods in stroke patients found that Holter monitors caught arrhythmias in only 9% to 19% of cases.
Event monitors extend the monitoring window to several weeks or even a full month. You wear the device throughout this period, and it either records continuously or activates when you press a button during symptoms. Adhesive patch monitors, which stick to your chest and record continuously for up to 14 days, have become a popular alternative. These longer-wear patches detected arrhythmias in 60% to 66% of patients in the same studies where Holter monitors caught far fewer. The difference is straightforward: more recording time means more chances to catch an episode.
Implantable Monitors for Long-Term Surveillance
When afib is strongly suspected but weeks of external monitoring haven’t captured it, or when a patient has had an unexplained stroke, doctors may recommend an implantable loop recorder. This is a small device, roughly the size of a USB flash drive, inserted just under the skin of the chest in a brief outpatient procedure. It continuously monitors heart rhythm for up to three years.
Implantable loop recorders use algorithms that detect irregularity in the spacing between heartbeats. When the device identifies a suspicious episode, it automatically saves the recording for a doctor to review later. These devices are commonly used after a stroke with no obvious cause, since undetected afib is one of the most common explanations. They’re also used for people with unexplained fainting episodes where a heart rhythm problem is suspected but hasn’t been proven.
Detection by Pacemakers and Defibrillators
People who already have an implanted pacemaker or defibrillator often learn they have afib through their device long before they notice any symptoms. These devices continuously monitor the upper chambers of the heart and flag episodes where the atrial rate exceeds a programmed threshold, typically between 175 and 220 beats per minute. These are called atrial high-rate episodes.
This type of detection has created a new clinical category of afib that exists somewhere between “no afib” and “confirmed afib.” The episodes can be as brief as 20 seconds or last more than 24 hours, and their significance for stroke risk is still being refined. One important caveat: not every flagged episode is real. Electrical noise or signal interference can create false positives, so doctors visually review the stored recordings before making treatment decisions.
What Smartwatches Can and Can’t Do
Consumer wearables like the Apple Watch have brought afib detection into everyday life. These devices use optical sensors on the wrist to track pulse patterns and can alert you when they detect irregularity. Some also offer a single-lead ECG recording you can take on demand by placing your finger on the watch.
The accuracy is genuinely impressive for a consumer product. A meta-analysis published in JACC: Advances found the Apple Watch ECG feature detected afib with 94.8% sensitivity and 95% specificity. Broader analyses of wrist-worn devices have reported similar numbers, around 97% sensitivity. These results mean the watch correctly identifies afib the vast majority of the time and rarely calls a normal rhythm abnormal.
There are limitations, though. Smartwatch screening in large, general populations only rarely uncovers a new afib diagnosis, largely because afib is uncommon in younger, healthier people who make up much of the smartwatch-wearing population. Current clinical guidelines note that mass screening with smartwatch apps hasn’t yet been proven to improve outcomes like stroke prevention. The technology is most useful for people who already have symptoms or known risk factors, where an alert can prompt timely medical evaluation. Any smartwatch finding still needs confirmation with a medical-grade ECG.
Tests After Afib Is Confirmed
Once afib is diagnosed, additional testing helps doctors understand what’s happening structurally in the heart and assess stroke risk. The most common follow-up is an echocardiogram, an ultrasound of the heart performed through the chest wall. This shows the size of the heart’s chambers (the left atrium often enlarges in afib), how well the heart muscle is pumping, and whether the heart valves are functioning properly.
A more specialized version, transesophageal echocardiography, involves passing an ultrasound probe into the esophagus to get a closer view of the heart’s back side. This is primarily used to check for blood clots in a small pouch called the left atrial appendage, which is the most common site for clot formation in afib. It’s typically done before a procedure called cardioversion, where the heart is electrically reset to a normal rhythm, to make sure no clot will be dislodged in the process.
Blood tests to check thyroid function, kidney health, and electrolyte levels are also standard, since these can both cause and worsen afib. Together, these tests shape the treatment plan by clarifying whether afib is the primary problem or a symptom of something else.